Anti-acetylcholine receptor antibody (AChR-Ab) titers and the AChR-Ab rates of change correlated with myasthenia gravis ...

Recently approved treatments for generalized myasthenia gravis (gMG), including complement and neonatal Fc receptor (FcRn) ...

Heightened focus on delays in diagnosing generalized myasthenia gravis (gMG) follows the promise of better results for some patients with newer treatments that include complement inhibitors and ...

Sex hormones have a profound impact on the brain, affecting disorders like stroke, epilepsy, and Alzheimer’s. A new review ...

A comprehensive review published today in Brain Medicine by leading neuroendocrinologist Professor Hyman M. Schipper from McGill University's Department of Neurology and Neurosurgery maps out the ...

Sugammadex (Bridion; Merck) is a small-molecule oligosaccharide, also known as a modified gamma cyclodextin, that was ...

COUR Pharmaceuticals has been around a while, but not until last year did the company solidify behind its ultimate mission ...

A comprehensive review published in Brain Medicine by leading neuroendocrinologist Professor Hyman M. Schipper from McGill ...

Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options ...

A woman from Ellsworth is navigating life with a rare neuromuscular disease. Tina Bruning learned of her diagnosis of Generalized Myasthenia Gravis or gMG in May of 2021.

BofA analyst Jason Gerberry lowered the firm’s price target on Immunovant (IMVT) to $38 from $45 and keeps a Buy rating on the shares. The firm ...

GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been detected in Pune. Early sym ...